Estramustine
From Wikipedia, the free encyclopedia
Estramustine
|
|
Systematic (IUPAC) name | |
(17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decahydro-6H-cyclopenta[a]phenanthren-3-yl) bis (2-chloroethyl)aminomethanoate | |
Identifiers | |
CAS number | |
ATC code | L01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C23H31Cl2NO3 |
Mol. mass | 440.403 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 20 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Estramustine (Emcyt®) is a chemotherapy agent used to treat prostate cancer. It is a combination of estrogen (specifically, estradiol) and mechlorethamine, a nitrogen mustard.